![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 0114-9954
Source: Reactions Weekly, Vol.1, Iss.1137, 2007-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etanercept/infliximab: Neutropenia: case report
Reactions Weekly, Vol. 1, Iss. 1166, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etanercept/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1139, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etanercept/infliximab: Leprosy: case report
Reactions Weekly, Vol. 1, Iss. 1429, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etanercept/infliximab: Cutaneous lymphocytic vasculitis: case report
Reactions Weekly, Vol. 1, Iss. 1110, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Etanercept/infliximab: Various toxicities: case report
Reactions Weekly, Vol. 1, Iss. 1347, 2011-01 ,pp. :